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ABSTRACT 
Computational methods to estimate muscle forces during walking are becoming more 
common in biomechanical research but not yet in clinical gait analysis. This systematic 
review aims to identify the current state-of-the-art, examine the differences between 
approaches, and consider applicability of the current approaches in clinical gait analysis. 
A systematic database search identified studies including estimated muscle force profiles of 
the lower limb during healthy walking. These were rated for quality and the muscle force 
profiles digitised for comparison.  
From 13.449 identified studies, 22 were finally included which used four modelling 
approaches: static optimisation, enhanced static optimisation, forward dynamics and EMG-
driven. These used a range of different musculoskeletal models, muscle-tendon characteristics 
and cost functions. There is visually broad agreement between and within approaches 
about when muscles are active throughout the gait cycle. There remain considerable 
differences (CV 7% to 151%, range of timing of peak forces in gait cycle 1% to 31%) in 
patterns and magnitudes of force between and within modelling approaches. 
The main source of this variability is not clear. Different musculoskeletal models, 
experimental protocols, and modelling approaches will clearly have an effect as will the 
variability of joint kinetics between healthy individuals. Limited validation of modelling 
approaches, particularly at the level of individual participants, makes it difficult to conclude if 
any of the approaches give consistently better estimates than others.  
While muscle force modelling has clear potential to enhance clinical gait analyses future 
research is needed to improve validation, accuracy and feasibility of implementation in 
clinical practice. 
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INTRODUCTION 
Knowing the force profiles of individual muscles during walking may help to better identify 
various neuro-musculoskeletal impairments from clinical gait analysis measurements and give 
a better understanding of how these affect walking. Patellar femoral pain, for example is often 
thought [1] to be due to an imbalance of force between agonist and antagonists and can lead to 
an excessive loading of knee joint and subsequent risk of developing degenerative joint 
conditions and injuries [2]. A better understanding of actual muscle forces in this condition, 
and many others, might help to identify the exact mechanism of gait impairments. Whilst 
muscle force estimation is becoming more and more common in biomechanical research, it is 
still not used routinely in a clinical context. 
A variety of computational techniques are now available to estimate muscle forces [3]. These 
modelling approaches have already been applied in a variety of research studies related to 
sport performance or clinical interventions [4-6]. Use of muscle force modelling has, 
however, not yet become established in a routine clinical gait analysis, despite that its 
potential utility was highlighted ten years ago [7] . A range of models is available 
incorporating different aspects of musculoskeletal morphology, kinematics and kinetics and 
muscle function based on a range of different assumptions [3, 5, 8]. Different cost functions 
have been applied to optimise force estimation and different models require different 
experimental inputs (kinematics, kinetics, EMG etc.). Each of these variations in model 
assumptions, optimisation techniques and input data have their own inherent limitations 
which may yield different force estimations and make it difficult for users in clinical gait 
analysis to select the most appropriate technique.  However, the consistency between these 
different modelling techniques and the feasibility of using a modelling approach to estimate 
muscle forces within clinical gait analysis has not yet been investigated. 
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To establish the potential feasibility and utility of muscle force modelling in clinical 
movement analysis a systematic review to compare the range of approaches is needed. This 
will allow identification of differences between models that cause differences in outputs and 
facilitate the development of a standardised protocol for the use of muscle force modelling 
which can be applied in a routine Clinical Gait Analysis (CGA). Therefore, the objective of 
this review is to facilitate a description of the state-of-the-art in muscle force estimation in 
gait analysis. Muscle force data will be extracted and pooled within the different modelling 
approaches identified in order to determine the consensus amongst different studies using the 
same modelling approach but also between different modelling approaches.  
The aims of the systematic review can, therefore, be summarised as follows: 
1. Identification of different techniques to estimate muscle forces in studies related to 
healthy human walking. 
2. Examination of muscle force profiles during walking and the consistency of these 
within and between different modelling approaches. 
3. Consideration of the applicability of current muscle force estimation approaches 
to clinical practice and discussion of what may be required for future research to 
establish implementation in clinical gait analysis.” 
At the same time, as kinetic information is used into the muscle force estimation process, a 
parallel systematic review of papers reporting joint moments was conducted. This will be 
described in the Methodology below but the results are presented separately in an Appendix.  
 
METHODS 
Search and selection strategy 
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To locate relevant papers, the following scientific databases were used (Jan 1990 - Dec 2016):  
- Ovid including Medline and AMED. 
- EBSCO, including CINHAL and SPORTDiscus. 
- Web of Knowledge.  
The start of the search period was set to 1990 which was when the first standardised 
musculoskeletal models which could be applied during walking were developed [9, 10].  
A free keyword search was undertaken with additional Medical Subject Headings (MeSH) 
[11]. The following search terms and their synonyms were included: gait, lower limb, 
moment, muscle, forces, mathematical model, modelling approaches, computer simulation, 
EMG driven, static optimisation, forward dynamics, dynamic optimisation, musculoskeletal 
model, and inverse dynamics. Furthermore, the bibliographies of identified papers were 
manually scanned to identify missing but relevant studies.  
Two independent reviewers (UT, RB) first screened titles and abstracts to exclude obviously 
irrelevant papers and then reviewed full text versions of the remaining paper to assess whether 
papers met the eligibility criteria listed below. Any disagreements between reviewers where 
resolved through discussion. Figure 1 presents a flow chart of the selection procedure. 
Eligibility criteria 
Participants 
Studies were included if they involved healthy adult participants (> 18 years). Studies which 
included healthy participants as a control group for comparison with another patient group 
were included but only data from those healthy controls were extracted. The maximum age 
was set to 60 years as walking kinematics [12] and muscle force capacity [13, 14] is 
understood to change beyond this age. 
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Force estimation approach 
Studies reporting estimates of muscle forces for individual healthy humans calculated from 
data captured during overground walking were included. Owing to ongoing debate as to the 
similarity of treadmill and overground walking [15, 16] only studies reporting estimates 
of muscle forces for individual healthy humans calculated from data captured during 
overground walking in a laboratory setting were included. Therefore, treadmill walking 
as well as studies of movements other than walking in environments other than a 
movement laboratory were excluded. The following muscles were identified as important in 
human walking [17, 18] and are included in data extraction: soleus, gastrocnemius, tibialis 
anterior, rectus femoris, vastii muscle group, hamstrings, gluteus maximus and medius, and 
iliopsoas. 
Studies presenting predictive simulations not based on data from individuals were excluded as 
clinical gait analysis requires models to be based on real experimental data. Gait analyses on a 
treadmill were not accepted as it may have changed the participants’ walking biomechanics  
[15]. Studies were only included if experimental data, joint kinematics and kinetics data 
and/or EMG activations had been captured within the researchers’ laboratory (no 
experimental data from external laboratories or previously published databases). If two or 
more modelling approaches were compared in any study then results from all modelling 
approaches were included. 
Outcome measures 
In order to facilitate the objective of comparing time varying muscle force estimations based 
on different modelling approaches, only studies providing graphical or numerical data of time 
varying muscle force estimations over the entire gait cycle or a defined part of the gait cycle 
were included.  
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Quality assessment tool and data synthesis 
A customised quality assessment tool was applied to rate and describe the quality of 
methodology and reporting of the musculoskeletal model and simulation. This was carried out 
independently by the two reviewers (UT, RB). Discrepancies in quality ratings between 
reviewers were settled by consensus in discussion.  
The systematic quality assessment procedure was designed by combining items from quality 
assessment tools for kinematic studies [19], randomised and non-randomised clinical 
interventions [20, 21] and additional items specific to muscle modelling approaches. Included 
studies were thus assessed on twelve aspects relating to the reported methodological quality, 
the research design of the study, the description of the experimental data collection and 
processing, the explanation of applied musculoskeletal models and modelling approaches, and 
the validation and discussion of limitations of the study. Some of these items were further 
broken down into sub-items. A full list of the items can be found in the electronical appendix 
(Figure S1). The score of an item and its sub-items were summed and transformed in a 
percentage of the maximum possible score. The overall score was then taken as the average of 
these relative scores allowing the highest score to be 100%, and the lowest to be 0%.  
Data extraction involved a graphical synthesis of all the muscle force patterns reported in the 
included studies. Estimated muscle force profiles were extracted and automatically digitised 
by the programme GetData Graph Digitiser (version 2.26, Sergei Fedorov, 2013, Russia). 
Accuracy of digitalisation was assessed by digitising our own experimental data three times. 
No appreciable differences (less than 1% of maximum value) between digitalisation and raw 
data were found. In the case that automatic digitalisation failed due to the quality of the graph, 
the graph was digitised by the operator manually selecting points on the graph. For those 
papers which focused exclusively on the stance phase of walking without stating the stance-
to-swing ratio of the gait cycle a 60%:40% ratio was assumed [22].  
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Digitised graphs were further analysed in Matlab (R2012b) by normalising them to the body 
weight of the participants of the study to account for influences occurring through different 
body sizes [23]. In case the specification of the participants’ body mass was missing the 
averaged body mass across all studies was used for normalisation. All muscle force profiles 
were averaged across studies to gain an overall mean at each time point in the gait cycle as 
well as one and two standard deviation bands. In cases when estimation of muscle force was 
reported separately for different muscle compartments (e.g., gastrocnemius lateralis and 
medialis, psoas and illiacus, vastus medialis and lateralis, hamstrings compartments) the data 
reported were summed up across compartments to generate a force profile for the whole 
muscle (gastrocnemius, iliopsoas, vastii, hamstrings).  
The grand mean ( ) of all studies will be presented and discussed as well as its standard 
deviation ( ) to describe the variability between studies. To facilitate comparisons between 
muscles generating different magnitudes of force, the coefficient of variation (CV)  
𝐶𝑉 = ∗ 100 (1) 
is also calculated for specific peak values, as has been done before for similar purposes [24]. 
 
RESULTS 
Figure 1 describes the development of the systematic review process. After the reviewing 
process 22 from 9870 originally identified studies were eligible for inclusion on the basis of 
presenting time varying data (graphically or numerically) of muscle force estimation over the 
gait cycle. 
The characteristics of included studies are detailed in Table 1. All but six studies were based 
on a single participant, while 80% of participants were male. Three studies did not give any 
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information about the participants’ characteristics [25-27], and further three gave only partial 
details [28-30]. In general, participants were asked to walk at their self-selected speed. Only 
nine out of all 19 studies, however, reported the actual walking speed (one other study defined 
cadence in steps/min [31]). Eight studies focused on the stance phase only which lasted, on 
average, 60% of the gait cycle. White and Winter [29] defined the gait cycle from toe off to 
toe off.  
Included studies broadly fell into four categories of modelling approaches, which are inverse 
dynamics (static optimisation SO, 14 studies), forward dynamics (FD, three studies), EMG-
driven models (six studies) and static optimisation combined with a dynamic optimisation 
criteria (enhanced-SO, four studies). 
Quality Appraisal of Included Studies 
Table 2 shows the quality assessment scores for each study. The overall quality with which 
studies were reported varied from 48% to 81%. Enhanced static optimisation models and 
EMG-driven models reached an overall higher score (average of 74% and 70%, respectively) 
compared to static optimisation (63%) and forward dynamics (58%) largely because these 
studies presented the experimental details in average more comprehensively. By contrast 
static optimisation and enhanced static optimisation studies tended to report their modelling 
approaches in more detail than the other two groups. 
Modelling techniques 
Static optimisation is an inverse dynamic technique. It solves the redundancy problem (more 
muscles spanning a joint than degrees of freedom exist) by dividing the experimental joint 
moments between the different muscles acting across the joint at each instant in time 
independently. The forward dynamics approaches identify the muscle activation pattern which 
led to the closest match of model and experimental kinematics over the whole gait cycle. 
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EMG-driven models additionally use experimental EMG excitations as input in the 
estimations to define muscular activation patterns. Four studies presented an enhanced static 
optimisation methods called physiological inverse dynamics [26] and computed muscle 
control [3, 32, 33], both including, additionally, a time-dependent characteristic, all 
representing the enhanced-SO group. 
Static, enhanced inverse and forward optimisation models used a variety of different 
optimisation functions to overcome the redundancy problem (Table 1). These functions 
minimise a specific cost function, which were either the sum of squared muscle activations, 
the sum of all muscle forces, the sum of (squared) muscle stress, or the minimisation of the 
metabolic energy (Table 1). EMG-driven studies incorporate matching of muscle activations 
to measured EMG signals as part of the cost function. 
Musculoskeletal models 
The most frequently used musculoskeletal models (twelve studies) were derived from the 
model of Delp and colleagues [34]. Each side consists of seven rigid bodies (pelvis, femur, 
patella, tibia/fibula, talus, foot, toes) with 43 musculotendon actuators acting between 
insertion and origins defined by digitising human bones. The actuators were Hill-type muscle 
models, adapted from Zajac’s work [35], and scaled in its maximum isometric force, the 
optimal-muscle fibre length, the pennation angle of the muscle, and the tendon slack length. 
Except Besier et al. [36], papers using the model of Delp adjusted the number of segments or 
the number of muscle tendon actuators depending on their focus of the study. Some included 
an upper body model, mostly by one segment representing the head arms and trunk (HAT) or 
others incorporated additional segments within the foot.  
Four studies [3, 8, 37, 38] used the musculoskeletal model of Anderson and Pandy [5] which 
is modelled as a 10-segment (HAT, pelvis, left and right thigh, left and right shank, left and 
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right hind- and forefoot) 23 degree of freedom linked model actuated by 54 muscle tendon 
muscles (24 muscles per leg). Muscle-tendon paths were adapted from the Delp model and the 
dynamics of the muscle-tendon unit from Zajac [35]. Six studies developed their own models. 
They differ in the number of muscle-tendon actuators and in the number of segments. The 
geometric parameters of the segments are either extracted from studies on cadavers [39, 40], 
through modelling approaches [41], or through analysis on living tissue [42, 43].  
Validation of estimated muscle forces 
A direct validation of estimated muscle forces is only possible with in-vivo techniques. 
However, good quality EMG data indicate when a muscle should be active. 18 of the 22 
muscle modelling studies compared their estimated muscle forces with EMG patterns. This 
was most often on the basis of on-off patterns of the muscle activity rather than on the whole 
profile of the EMG signal. The researchers rarely captured EMG data of their own 
participants and mostly used EMG patterns found in the literature. Only six studies compared 
the muscle force estimation to experimental EMG data that they had captured themselves. The 
other studies which used EMG as a validation tool included EMG excitations from Inman 
[44], Perry [45], Hof [46], or Anderson and Pandy [8]. Leardini and O’Connor [28] do not 
state their source of EMG patters used in their graph for validation. Three EMG-driven 
studies used experimental joint moments or power and compared them to estimated joint 
moments and powers calculated through the estimated muscle force estimations. Four studies 
did not validate their muscle force estimations at all. 
Outcome measures 
Four studies [3, 8, 26, 47]  compared two or more modelling techniques with each other (see 
Table 1) which were all separately included into the digitising process. Results from two static 
optimisation approaches from Anderson and Pandy [8] (with and without inclusion of force-
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length-velocity curve) were averaged for inclusion in the analysis, as their “force-length-
velocity properties of muscle had little influence on the static solutions” [8]. 
Table 3 describes maximum peak forces, its standard deviation and CV. The average force 
distribution across a gait cycle are presented in Figure 2. Note that studies which included 
EMG-driven models did not include force estimations for muscles acting on the hip 
(iliopsoas, gluteus maximus and medius). 
In general, the shape of the estimated muscle force profiles show broad agreement between 
modelling approaches (Figure 2). For some of the muscles, however, differences exist. 
Forward dynamic solutions are particularly susceptible to sharp peaks and discontinuities 
leading to more variablity between model standard deviation profiles in the muscle force 
estimations than other techniques. There is broad agreement within and between approaches 
as to when muscles are not active but considerable variability in the estimated magnitude of 
muscle force when they are active. 
Generally speaking, the EMG driven approaches show agreement especially with static 
optimisation and enhanced-SO but suggest smaller magnitudes of force and some residual 
activation of muscles at times when the other approaches suggest no activation. This is 
especially true for rectus femoris, the vasti, tibialis anterior and, to a lesser extent, soleus. An 
exception is that the EMG driven models suggest higher forces in the tibialis anterior during 
swing, which is confirmed by enhanced-SO. It is also interesting that forward driven models 
do not predict tibialis activation at all in first double support in contrast to the other 
approaches, while static optimisation has no pronounced second peak in mid swing. 
The standard deviation bars in Figure 2 show that, within individual modelling approaches, 
there is general agreement between studies as to when muscles are inactive. On the other 
hand, for all muscles where data is available from three or more static optimisation and 
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forward dynamic models there is considerable variability in the magnitude of the forces 
during active periods. The enhanced-SO and EMG driven models appear to show more 
consistent estimates of muscle force. These findings are confirmed by the tabulated average 
and standard deviations of maximal force generation (Table 3).  Most of the coefficients of 
variation are above 50% reflecting considerable variability in force estimates between models, 
even within approaches. Lowest CV values are presented in average for enhanced-SO with 
only two muscles exceeding 40% (first peak of rectus femoris, gluteus medius). 
 
DISCUSSION 
This is the first systematic synthesis of different computational methods to estimate muscle 
forces during walking, to examine the differences between approaches, and to consider their 
potential for use in clinical gait analysis. The study showed a broad agreement in when 
muscles are active between and within modelling approaches, however, with considerable 
differences between the estimated patterns and magnitudes of force generation.  
Quality of studies 
The quality rating of studies varies quite considerably. It is important to recognise that this 
primarily reflects the quality of how comprehensively the techniques and results have been 
reported and does not necessarily reflect the quality with which the research was conducted. A 
number of studies scored particularly badly [8, 27, 48] because the focus on modelling issues 
led to omissions of key experimental details. The specific task and pre-modelling signal 
processing issues were particularly badly reported across all studies. All but five studies [3, 
29, 30], however, scored zero on at least one category. In such a complex area, and with few 
studies to identify which signals and parameters models are most sensitive to, it is important 
that all aspects of data collection and modelling are adequately reported. 
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Variability of outputs 
Broadly speaking, the different models agree in predictions as to when specific muscles are 
active within the gait cycle. There is considerable variability, however, in predictions of the 
peak muscle forces, with the coefficient of variation across studies typically considerably 
greater than 50%. The source of this variability is not clear. The authors looked for evidence 
that papers with higher quality rating or published more recently showed more consistent 
results but this did not appear to be the case (noting, as in the paragraph above, that simply 
because a study has been reported well does not guarantee that it has been conducted well). 
Four studies have compared outputs of different models [3, 8, 26, 47]. Whilst Anderson and 
Pandy present convincing evidence that static optimisation and forward dynamics are 
“practically equivalent” [8] the other studies are less convincing. The study of Lin et al. [3] is 
particularly interesting in that three differing modelling techniques were applied with the 
same biomechanical model. Whilst the authors concluded that the patterns of muscle loading 
were “similar”, substantial differences in both the pattern of activation and peak load values 
can be seen for at four of the eight muscles for which walking data is presented. (The study 
even shows quite substantial differences between two different implementations of exactly the 
same simulation). 
Another potential contributor to variability in model outputs (particularly between different 
papers) is variability in model inputs. Data presented and discussed in the appendix suggests 
considerable variability between joint kinetics presented in different studies. Some of this may 
result from different analytical techniques but Pinzone et al. [49] have recently commented on 
the extent of inter-individual variability in joint kinetics even after using non-dimensional 
normalisation techniques to effectively remove systematic variation with leg length, mass or 
age. Most of the modelling studies reported in this paper have been based on one individual 
and differences between studies may well reflect, in part, differences in the individuals 
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studied. Similarities in the average traces across studies within each of the modelling 
approches, despite large variability between studies, might reflect this. It would also explain 
why similarity between the EMG driven studies (which all averaged results across a number 
of individuals) appear more consistent than models in the other categories (which generally 
presented results from just one individual). 
Validation 
Given the variability between model outputs some sort of validation is required to distinguish 
which are actually succeeding [50]. Seven of the 22 studies made no attempt at validating 
outputs. A further four did so by comparison with data taken from the literature rather than the 
individuals modelled (which might be an important issue if there is considerable variability in 
joint kinetics between individuals as suggested above).  
Validations are generally undertaken against EMG measurements. This is useful to give a 
broad indication of whether the estimated patterns of force generation are sensible. However, 
it is of limited use in validating the magnitude of the force estimates, given that there is no 
simple relationship between the EMG signal and the magnitude of force generation within the 
muscles [7]. Recent studies comparing joint contact loads with those measured by transducers 
[51] are more convincing but also more restricted in who they can be applied to. Given the 
potential importance of kinetic variability (and thus presumably EMG variability) between 
individuals, validation at the level of the individual is important and comparisons between 
different techniques should either be conducted on the same datasets or on a sufficient number 
of individuals for these differences to be averaged out.  
Therefore, full quality scores were given when estimated muscle forces were compared 
against EMG measured parallel to the walking trial of interest. However, considering 
the non-linear relationship between EMG and muscle forces, validation against EMG 
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may not be the best or only method to achieve clinical validation or implementation. 
Instead, validation against parameters like sensitivity of muscle force estimations to 
changes in the musculoskeletal system (caused by injuries, treatments or training) and 
correlations to other metrics of clinical impairment known to be prognostic of outcomes 
may help to improve utility and implementation of force estimation within clinical gait 
analysis. 
 
APPLICABILITY OF CURRENT MUSCLE FORCE ESTIMATION TECHNIQUES 
TO CLINICAL GAIT ANALYSIS: RECOMMENDATIONS FOR FUTURE 
RESEARCH 
The wide range of papers yielded by the search suggests that estimation of muscle force 
modelling is a practical technique for healthy participants. Processing times  [15 minutes for 
CMC, a few seconds for static optimisation on a "standard" personal computer; 52] are no 
longer a barrier to clinical application.  
There is general agreement in the broad pattern of activity in most muscles (particularly in 
when in the gait cycle they are on or off) which is also in broad agreement with EMG 
measurements. (Techniques giving outputs at variance with this broad consensus should, 
however, now be treated with considerable scepticism.) Differences from this consensus in 
data from patients might provide information to augment conventional clinical outputs such as 
joint kinematics and kinetics. Clinical interpretation of these new outputs will have to be 
based upon an in depth understanding of their biomechanical basis and consequent 
limitations. This is similar to the manner in which some clinical centres currently incorporate 
estimates of muscle tendon unit length in their interpretive processes. 
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Part of this consideration must be that the underlying assumptions of modelling and 
simulation are inconsistent with the pathology. Many techniques assume an optimisation of 
some aspect of neuromuscular function whereas most clinical gait analysis is of people in 
whom the body’s own optimiser, the central nervous system, is deficient in some way. 
Exploring the applicability of such techniques to musculoskeletal pathologies, in which this is 
less of an issue, may thus be more appropriate than in neuromuscular pathologies. 
Furthermore, musculoskeletal modelling must distinguish between adults, children, and 
elderly people, as the neuromuscular and skeletal system changes considerable 
according to age. Further research should systematically review musculoskeletal 
modelling according to pathology and age.  
There is considerable variability between techniques in the patterns of activation and the 
magnitude of the forces generated and the reasons for this are not clear. According to the 
results of this review, none of the included techniques can be recommended to be 
preferential over the others. More research is needed to prove, firstly, the potential 
advantages of each technique (e.g. activation-contraction cycle in forward dynamic 
methods) and, secondly, the utility of muscle force estimation in clinical gait analysis 
(e.g. sensitivity to changes caused by injuries, treatments etc.). For the moment, any 
clinical implementation should thus focus on that of a single technique in comparison only 
with normative reference data from that technique. 
Force estimations are known to be highly sensitive to model parameters leading to a widely 
held assumption that person specific models are preferable to generic models. This needs to 
be balanced by the difficulty in estimating many of the parameters which introduces 
considerable uncertainty as to how differences from reference data should be interpreted (do 
differences between patients and reference data occur principally due to differences in 
individualised model parameters or due to a pathologic change in movement pattern?). 
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Some scaling of models is essential, but it might be that limited and systematic scaling leads 
to data that can be more easily interpreted than fully customised models.  
In summary, this review provides some justification for exploratory clinical use of muscle 
force estimation techniques. It is likely to be more useful in musculoskeletal than 
neuromuscular conditions and particularly in individuals with fairly normal musculoskeletal 
anatomy but an abnormal gait pattern.  
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Table 1. Relevant studies included into the systematic review process; SO=static optimisation, 
FD=forward dynamics, ED=EMG-driven, ID=inverse dynamics, CMC=computed muscle 
control, a=activation, e=excitations, f=force, s=stress, BC=Bertec Corporation, MAC=Motion 
Analysis Corporation, MLS=Motion Lab System, S=stance, GC=gait cycle. 
Authors [ID] 
Mathematical 
model (model 
(cost function)) 
Measurement 
equipment (motion system 
(Hz), force plates (Hz), EMG 
(Hz)) 
Gait (m/s, 
stance or 
GC) 
Participants 
(number, BW 
(kg), BH (m), age) 
     
Ackland et al. [37] SO (∑a2) Vicon (120), --, // free, S 1, 70, 1.78, 26 
Anderson & Pandy 
[8] 
SO (∑a2),  
FD (metab. energy) 
--, --, // 1.12, GC 1, 70.1, 1.77, 26 
Besier et al. [36] ED (∑moments) MAC (60), BC (2400), MLS 
(2400) 
1.49, S 16, 74.2, 1.79, 28 
Bogey et al. [53] ED (∑moments) Vicon (100), Kistler (600), 
needle  
1.37, GC 10, 76, 1.78, 27 
Bogey et al. [30] ED (∑power) MAC (100), AMTI (600), 
needle (2500) 
free, GC 16, 73.9, --, 27 
Buchanan et at. [25] ED (∑moments) Qualysis (--), AMTI (--), 
Noraxon (1000) 
free, S 1, --, --, -- 
Collins et al. [48] SO (∑f) Vicon (50), Kistler (50), // --, GC 1, 69.8, 1.76, 26 
DeGroote et al. [26] SO (∑a2) 
physical ID (∑a2) 
Qualysis (--), AMTI  (--), // --, GC 1, --, --, -- 
Fraysse et at. [22] SO (∑s2) MAC (100), AMTI, (100) // free, GC 1, 64, 1.74, 23 
Glitsch & Baumann 
[54] 
SO (∑s2) Selspot II (500), Kistler 
(500), // 
1.5, S 1, 85, 1.78, 31 
Hase & Yamazaki 
[27] 
FD (metab. energy) Hamasatsu Photonics PSD 
system C3570 (--), Kyowa 
Dengyo EP-386 (--), // 
1.39, GC 1, --, --, -- 
Heintz & Gutierrez-
Farewik [47] 
SO (∑s2), 
ED (∑moments) 
Vicon (50), Kistler (--), 
MLS (1000) 
free, GC 1, 59.3, 1.64, 34 
Komura & Nagano 
[55] 
SO (∑s) Vicon (--), --, // --, S 1, 51, 1.64, 50 
Komura et al. [56] SO (∑s2) --, --, // 1.0, GC 1, 51, 1.64, 50 
Leardini & O’Connor 
[28] 
SO (--) ElitePlus BTS (--), Kistler (-
-), // 
--, S 1, 59, 1.74, -- 
Lim et al. [38] SO (∑a2) Vicon  (120), AMTI (1080) 1.4, S 10, 65.9, 1.70, 25 
Lin et al. [3] SO (∑a2),  
FD (∑a2 + ∑errors), 
CMC (∑a2) 
Vicon (250), Kistler (--), // 1.61, GC 1, 64, 1.77, 25 
Rodrigo et al. [31] SO (metab. energy) --, --, // 111 st/min, 
GC 
1, 70, 1.70, 25 
Silvia & Ambrosio 
[57] 
SO (∑s) --, --, // free, GC 1, 70, 1.70, 25 
Thompson et al. [32]   CMC (∑e2) VICON (150), Bertec (600) 1.32, GC 7, 72.8, 1.74, 22 
Valente et al. [33] CMC (--) VICON (100), AMTI (1000) free, GC 5, 82, 1.82, 26 
White & Winter [29] ED (∑moments) Bolex (50+200), AMTI 
(1000), -- (500) 
--, S 1, --, --, 28 
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Table 2.  Individual (for each study) and average (across all studies of the same modelling approach) quality scores in percentage [%]. 
Authors [ID] Aim 
Partici-
pants 
Task 
Equip-
ment 
Proces-
sing 
Kinema-
tic  
Kinetic  Output 
Valida-
tion 
Muscle 
Models 
EMG 
Discus-
sion 
Overall 
score 
               
Ackland et al. [37] 100 80 25 67 100 43 67 100 0 100 --- 50 67 
Anderson & Pandy [8] 100 33 0 0 0 43 67 50 100 100 0 100 49 
Besier et al. [36] 100 80 75 67 100 100 60 100 0 100 94 100 81 
Bogey et al. [53] 100 60 100 83 100 29 67 50 0 100 63 100 71 
Bogey et al. [30] 100 60 100 92 75 29 67 50 50 100 63 50 70 
Buchanan et at. [25] 100 17 25 50 0 14 33 50 100 100 100 100 57 
Collins et al. [48] 100 33 25 50 0 57 67 50 100 80 25 50 53 
DeGroote et al. [26] 100 17 0 33 0 75 100 50 100 100 25 100 58 
Fraysse et at. [22] 100 80 25 67 50 71 67 75 0 100 --- 100 67 
Glitsch & Baumann [54] 100 83 100 92 0 29 100 50 100 80 75 100 76 
Hase & Yamazaki [27] 100 17 0 33 0 43 33 50 50 100 --- 100 48 
Heintz & Gutierrez-Farewik [47] 100 100 33 50 0 86 67 50 100 100 88 100 73 
Komura & Nagano [55] 100 100 0 17 0 43 67 50 50 100 --- 100 57 
Komura et al. [56] 100 100 0 17 0 80 67 50 50 100 --- 0 51 
Leardini & O’Connor [28] 100 67 0 17 0 86 0 50 0 100 63 100 49 
Lim et al. [38] 100 90 67 83 50 75 33 100 100 100 50 100 77 
Lin et al. [3] 100 100 67 50 100 57 60 50 100 100 25 100 76 
Rodrigo et al. [31] 100 100 67 50 100 100 100 50 0 100 --- 100 72 
Silvia & Ambrosio [57] 100 83 33 50 0 71 100 50 0 100 --- 100 62 
Thompson et al. [32] 100 100 75 100 0 75 --- 100 100 80 100 100 81 
Valente et al. [33] 100 100 25 67 25 63 --- 100 100 60 75 100 71 
White & Winter [29] 100 33 25 92 50 43 67 50 100 100 50 100 68 
              
Static Optimisation 100 76 32 46 29 65 69 59 57 97 44 86 63 ± 11 
Forward Dynamics 100 50 22 28 33 48 53 50 83 100 13 100 58 ± 16 
EMG-driven 100 58 60 72 54 50 60 58 58 100 76 92 70 ± 8 
Enhanced SO 100 95 48 71 44 67 64 81 75 85 67 100 74 ± 6 
Average 100 70 39 56 34 60 64 63 59 95 60 89 65 ± 11 
28 
 
Table 3. Average and standard deviation of peak muscle force with coefficient of variation 
(expressed as a %) and average timing of the peak within the gait cycle for stance and swing; 
GC= gait cycle, SD= standard deviation, FD= forward dynamics, SO= static optimisation, 
CV= coefficient of variation, EMG-dr.= EMG-driven. 
  Maximum  Maximum 
Muscle Modelling approach Average SD 
CV 
(%) 
GC 
(%) 
  Average SD 
CV 
(%) 
GC 
(%) 
           
Tibialis SO (7) 5.6 4.3 78 6  2.6 1.7 63 96 
anterior Enhanced-SO (1) 4.4 -- -- 0  4.5 -- -- 65 
 FD (1) -- -- -- --  1.1 -- -- 65 
 EMG-dr. (3) 3.0 2.8 94 4  2.8 1.0 35 78 
           
Gastroc- SO (11) 14.8 7.1 48 44      
nemius Enhanced-SO (2) 14.9 3.0 20 45      
 FD (2) 12.4 0.9 8 45      
 EMG-dr. (4) 13.5 2.9 21 46      
           
Soleus SO (12) 20.0 9.7 48 47      
 Enhanced-SO (4) 18.5 4.0 22 52      
 FD (2) 23.1 1.6 7 48      
 EMG-dr. (5) 16.5 7.8 47 46      
           
Rectus  SO (9) 2.7 1.6 58 21  4.2 2.4 57 54 
femoris Enhanced-SO (3) 2.6 2.0 76 5  4.4 1.7 38 52 
 FD (3) 2.3 2.8 120 10  5.9 7.8 133 51 
 EMG-dr. (2) 1.7 1.4 80 12  1.9 -- -- 63 
           
Vastii SO (9) 13.3 9.3 70 12  3.1 2.3 75 62 
 Enhanced-SO (4) 8.7 2.7 30 13  3.4 1.2 37 69 
 FD (2) 14.1 3.4 24 12  5.2 0.8 16 62 
 EMG-dr. (2) 10.3 7.0 68 13  -- -- -- -- 
           
Hamstrings SO (9) 7.2 5.3 73 2  4.6 1.7 37 94 
 Enhanced-SO (1) 6.0 -- -- 3  2.8 -- -- 96 
 FD (2) 4.0 2.4 61 2  3.5 0.7 21 94 
 EMG-dr. (2) 4.1 2.6 63 2  -- -- -- --            
Iliopsoas SO (5) 7.2 7.9 111 47      
 Enhanced-SO (2) 24.8 3.9 16 49      
 FD (3) 9.0 12.6 140 50                 
Gluteus max SO (6) 4.6 3.5 78 13      
 Enhanced-SO (3) 3.6 1.3 37 12      
 FD (4) 4.8 4.9 102 12                 
Gluteus med SO (7) 14.7 22.2 151 8      
 Enhanced-SO (2) 19.1 21.3 112 15      
 FD (2) 27.9 26.4 94 12      
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Figure 1. Flow chart describing the process of the systematic review. Red arrows indicate 
exclusion, green arrows inclusion of papers. “No walking in lab” indicates other 
movements than walking or other investigation environments other than a movement 
laboratory. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Excluded by title and abstract analyses 
13.331 
No journal article:  546 
No walking in lab:            9.505 
No healthy/ adult/ human:              2.107 
No force/ moments:  831 
No lower extremity:  250 
Treadmill:   50 
Other:    42 
 
Papers included in quality analysis 
118 
Excluded papers 
82 
No human healthy adults:  12 
No muscle force/ moment graphs: 38 
Refer to second source:  11 
Treadmill:   8 
No experimental data:  2 
Review/ conference article: 2 
No normal walking speed: 2 
No method description:  4 
Not barfeet   3 
Included papers by reference 
search 
7 
 
Muscle forces 
9 
Joint moments 
21 
 
Identified papers by database search 
OVID 6.598 
EBSCO 2.548 
Web of knowledge 8.656 
Total after deleting duplicates 
13.449 
Joint moments and Muscle forces 
13 
Papers finally included 
43 
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Figure 2. Mean and one and two standard deviation of extracted muscle forces of the lower 
limb during healthy walking divided in static optimisation, EMG-driven models and forward 
dynamics. Curves of CMC of Lin et al. (black) and physiological inverse dynamics of 
31 
 
DeGroote et al. (grey) are in the column “other”. Forces are shown in Newton/body mass, 
numbers of included studies are shown in brackets.  
